Oppenheimer Holdings Stock News

Jessica Slack-Jell and Rebecca Oppenheimer, the granddaughters of industrialist Harry Oppenheimer, gave ActionSA multimillion-rand donations for the November 1 polls.

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Stock analysts at Oppenheimer decreased their FY2021 earnings per share estimates for PMV Pharmaceuticals in a report released on Monday, November 15th. Oppenheimer analyst J. Jones now forecasts that the company will post earnings per share of ($1.22) for the year, down from their previous forecast of ($1.14). Oppenheimer has []

Gamida Cell (NASDAQ:GMDA) had its target price lowered by Oppenheimer from $17.00 to $15.00 in a report issued on Tuesday morning, The Fly reports. The brokerage currently has an outperform rating on the stock. Several other analysts have also issued reports on the company. Alliance Global Partners started coverage on Gamida Cell in a research []

Isoray, Inc. (NYSEAMERICAN:ISR) Equities research analysts at Oppenheimer lowered their FY2022 earnings per share estimates for Isoray in a research note issued to investors on Thursday, November 11th. Oppenheimer analyst S. Kalia now forecasts that the healthcare company will post earnings of ($0.04) per share for the year, down from their previous estimate of []

Integral Ad Science Holding Corp. (NASDAQ:IAS) Stock analysts at Oppenheimer issued their Q2 2022 earnings per share (EPS) estimates for shares of Integral Ad Science in a report released on Thursday, November 11th. Oppenheimer analyst J. Helfstein anticipates that the company will post earnings of $0.01 per share for the quarter. Oppenheimer currently has []

WhiteHorse Finance, Inc. (NASDAQ:WHF) Stock analysts at Oppenheimer upped their Q4 2021 earnings estimates for shares of WhiteHorse Finance in a research report issued on Wednesday, November 10th. Oppenheimer analyst M. Penn now anticipates that the investment management company will earn $0.38 per share for the quarter, up from their previous forecast of $0.37. []

Aeva Technologies, Inc. (NYSE:AEVA) Oppenheimer decreased their FY2021 earnings per share estimates for Aeva Technologies in a report released on Thursday, November 11th. Oppenheimer analyst C. Rusch now forecasts that the company will post earnings per share of ($0.50) for the year, down from their previous estimate of ($0.42). Oppenheimer also issued estimates for []

Prometheus Biosciences (NASDAQ:RXDX) was downgraded by Oppenheimer from an outperform rating to a market perform rating in a research report issued to clients and investors on Monday, Price Targets.com reports. They currently have a $35.00 price objective on the biopharmaceutical companys stock. Oppenheimers price target points to a potential downside of 4.32% from the companys []

Gamida Cell (NASDAQ:GMDA) had its target price lowered by stock analysts at Oppenheimer from $17.00 to $15.00 in a report issued on Tuesday, The Fly reports. The firm currently has an outperform rating on the stock. Oppenheimers target price indicates a potential upside of 341.18% from the companys current price. A number of other equities []

Wells Fargo & Company assumed coverage on shares of Runway Growth Finance (NASDAQ:RWAY) in a report issued on Monday, PriceTargets.com reports. The firm issued an overweight rating and a $15.00 price target on the stock. A number of other research firms also recently commented on RWAY. Oppenheimer initiated coverage on Runway Growth Finance in a []

Gladstone Land Co. (NASDAQ:LAND) Research analysts at Oppenheimer reduced their Q4 2021 EPS estimates for Gladstone Land in a research note issued to investors on Thursday, November 11th. Oppenheimer analyst M. Penn now expects that the real estate investment trust will post earnings of $0.17 per share for the quarter, down from their prior []

Compass, Inc. (NYSE:COMP) Stock analysts at Oppenheimer raised their FY2021 earnings estimates for shares of Compass in a research report issued to clients and investors on Thursday, November 11th. Oppenheimer analyst J. Helfstein now forecasts that the company will post earnings of ($1.33) per share for the year, up from their prior estimate of []

ContextLogic Inc. (NASDAQ:WISH) Research analysts at Oppenheimer increased their FY2021 earnings per share (EPS) estimates for ContextLogic in a research report issued on Wednesday, November 10th. Oppenheimer analyst J. Helfstein now expects that the company will post earnings per share of ($0.57) for the year, up from their prior forecast of ($0.67). Oppenheimer has []

A price cut from an analyst had some traders hitting the sell button.

Wix.com (NASDAQ:WIX) had its target price cut by equities research analysts at Oppenheimer from $275.00 to $250.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has an outperform rating on the information services providers stock. Oppenheimers price objective points to a potential upside of 25.04% from the []